Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 °C for 6 days

被引:44
作者
Buchta, C
Felfernig, M
Höcker, P
Macher, M
Körmöczi, GF
Quehenberger, P
Heinzl, H
Knöbl, P
机构
[1] Vienna Med Univ, Dept Blood Grp Serol & Transfus Med, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Anaesthesiol, Vienna, Austria
[3] Med Univ Vienna, Inst Med & Chem Lab Diagnost, Vienna, Austria
[4] Med Univ Vienna, Dept Med Comp Sci, Vienna, Austria
[5] Med Univ Vienna, Dept Internal Med 1, Vienna, Austria
关键词
coagulation factor stability; FFP; S/D plasma; storage conditions;
D O I
10.1111/j.1423-0410.2004.00552.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives Transfusion of fresh-frozen plasma is still a pillar in emergency medicine for using to prevent dilutional coagulopathy or disseminated intravascular coagulation after severe blood loss, but thawing procedures can delay its availability. On the other hand, the wastage of plasma, once thawed and not transfused within a defined time-period, represents an inefficient handling of economic resources and is contradictory to blood donor intentions. In this study we investigated the stability of coagulation factor activities and plasma protein levels during 6 days of storage of thawed solvent/detergent (S/D)-treated plasma at +4 degreesC. Our results may form the basis for reconsideration of expiry times of thawed S/D-treated plasma. Materials and Methods Five units of S/D-treated plasma (Octaplas(R)) were thawed and warmed to 20 degreesC, then recooled and stored at +4 degreesC for 6 days. The activities of coagulation factors II, V, VII, VIII, IX, X, XI and XII, fibrinogen, antithrombin (AT), protein C, protein S and von Willebrand factor antigen (vWF:Ag) were measured on days 0, 1, 2, 3 and 6. Results Except for protein S, the activities of all coagulation factors and inhibitors were at least 0.5 U/ml during storage at 4 degreesC for 6 days. The mean levels, during storage, of factors IX, X, XI and XII, vWF:Ag, fibrinogen and protein C were at least 94%, and of factors II, V and VIII, and AT at least 78%, of the levels immediately after thawing; the activity of factor VII decreased to 83% and of protein S to 43% of the baseline values. Conclusions Thawed S/D-treated plasma stored at +4 degreesC for up to 6 days still contains sufficient coagulation activities and plasma proteins to be regarded as suitable for transfusion in the established indications.
引用
收藏
页码:182 / 186
页数:5
相关论文
共 15 条
[1]   Hemovigilance network in France:: organization and analysis of immediate transfusion incident reports from 1994 to 1998 [J].
Andreu, G ;
Morel, P ;
Forestier, F ;
Debeir, J ;
Rebibo, D ;
Janvier, G ;
Hervé, P .
TRANSFUSION, 2002, 42 (10) :1356-1364
[2]   In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma [J].
Beeck, H ;
Hellstern, P .
VOX SANGUINIS, 1998, 74 :219-223
[3]   Bacterial contamination of blood products: Factors, options, and insights [J].
Depcik-Smith, ND ;
Hay, SN ;
Brecher, ME .
JOURNAL OF CLINICAL APHERESIS, 2001, 16 (04) :192-201
[4]   Bacterial contamination and transfusion safety: experience in the United States [J].
Dodd, RY .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2003, 10 (01) :6-9
[5]  
*EUR COMM, 2002, GUID PREP US QUAL AS
[6]   MODULATION OF FIBRINOGEN CONTENT IN CRYOPRECIPITATE BY TEMPERATURE MANIPULATION DURING PLASMA PROCESSING [J].
FARRUGIA, A ;
GRASSO, S ;
DOUGLAS, S ;
HARRAP, R ;
OATES, A ;
YOUNG, I ;
JAMES, J ;
WHYTE, G .
TRANSFUSION, 1992, 32 (08) :755-759
[7]   CONTROL OF LARGE-SCALE PLASMA THAWING FOR RECOVERY OF CRYOPRECIPITATE FACTOR-VIII [J].
FOSTER, PR ;
DICKSON, AJ ;
MCQUILLAN, TA ;
DICKSON, IH ;
KEDDIE, S ;
WATT, JG .
VOX SANGUINIS, 1982, 42 (04) :180-189
[8]   Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy [J].
Hellstern, P ;
Haubelt, H .
THROMBOSIS RESEARCH, 2002, 107 :S3-S8
[9]   Replacement of massive blood loss [J].
Hiippala, S .
VOX SANGUINIS, 1998, 74 :399-407
[10]   SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available [J].
Horowitz, MS ;
Pehta, JC .
VOX SANGUINIS, 1998, 74 :231-235